Sanofi - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 11, 2026, for the 2025 Q4 period, Sanofi held in its portfolio 8 assets valued at $310,414,825 (i.e. $310.42M).

The most valuable assets in the portfolio included: MeiraGTx Holdings plc ($96.97M), Inhibrx Biosciences, Inc. ($91.48M), and Novavax ($46.24M).

The chart below shows the top 8 valuable assets, and the table below shows the top 8 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Sanofi Portfolio

MeiraGTx Holdings plc

Inhibrx Biosciences, Inc.

Novavax

AnaptysBio

Immuneering Corp

MapLight Therapeutics Inc.

Eledon

Q32 Bio Inc.

Sanofi - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
MeiraGTx Holdings plc	12197737	96972009	COM
Inhibrx Biosciences, Inc.	1157926	91476154	COM
Novavax	6880481	46236832	COM NEW
AnaptysBio	821917	39846536	COM
Immuneering Corp	2708559	17822318	CLASS A COM
MapLight Therapeutics Inc.	912041	16020000	COM
Eledon	814980	1230620	COM
Q32 Bio Inc.	244083	810356	COM